Tags

Type your tag names separated by a space and hit enter

The use of hyaluronic acid as an adjuvant in the management of mucositis.
J Biol Regul Homeost Agents. 2017 Dec 27; 31(4 Suppl 2):115-118.JB

Abstract

In recent years, with an increase in the number of implants, there has been a related increase in cases of pathologies related to infections around the implant site and on the implant surface i.e. mucositis and peri-implantitis. The purpose of this pilot study is to evaluate the potential efficacy of nebulized hyaluronic acid in the management of mucositis. The results of the statistical analysis demonstrate that there was no difference between the pocket depth as measured in the treated sites at time 0 (pre-treatment) and time 1 (15 days weeks post-treatment). However, the difference between bleeding on probing as measured at time 0 and time 1 indicated an improvement on both sides, with a slightly greater improvement on the side treated with HA.

Authors+Show Affiliations

Lopez MA
Private practice, Rome, Italy.
Manzulli N
Private practice, Rome, Italy.
D'Angelo A
Private practice, Rome, Italy.
Candotto V
Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Casale M
Unit of Otolaryngology, University Campus Bio-Medico, Rome, Italy.
Lauritano D
Department of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.

MeSH

Dental ImplantsHemorrhageHumansHyaluronic AcidMucositisPeri-ImplantitisPilot Projects

Pub Type(s)

Clinical Trial
Journal Article

Language

eng

PubMed ID

29202570

Citation

Lopez, M A., et al. "The Use of Hyaluronic Acid as an Adjuvant in the Management of Mucositis." Journal of Biological Regulators and Homeostatic Agents, vol. 31, no. 4 Suppl 2, 2017, pp. 115-118.
Lopez MA, Manzulli N, D'Angelo A, et al. The use of hyaluronic acid as an adjuvant in the management of mucositis. J Biol Regul Homeost Agents. 2017;31(4 Suppl 2):115-118.
Lopez, M. A., Manzulli, N., D'Angelo, A., Candotto, V., Casale, M., & Lauritano, D. (2017). The use of hyaluronic acid as an adjuvant in the management of mucositis. Journal of Biological Regulators and Homeostatic Agents, 31(4 Suppl 2), 115-118.
Lopez MA, et al. The Use of Hyaluronic Acid as an Adjuvant in the Management of Mucositis. J Biol Regul Homeost Agents. 2017 12 27;31(4 Suppl 2):115-118. PubMed PMID: 29202570.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The use of hyaluronic acid as an adjuvant in the management of mucositis. AU - Lopez,M A, AU - Manzulli,N, AU - D'Angelo,A, AU - Candotto,V, AU - Casale,M, AU - Lauritano,D, Y1 - 2017/12/27/ PY - 2017/12/6/entrez PY - 2017/12/6/pubmed PY - 2019/2/26/medline SP - 115 EP - 118 JF - Journal of biological regulators and homeostatic agents JO - J Biol Regul Homeost Agents VL - 31 IS - 4 Suppl 2 N2 - In recent years, with an increase in the number of implants, there has been a related increase in cases of pathologies related to infections around the implant site and on the implant surface i.e. mucositis and peri-implantitis. The purpose of this pilot study is to evaluate the potential efficacy of nebulized hyaluronic acid in the management of mucositis. The results of the statistical analysis demonstrate that there was no difference between the pocket depth as measured in the treated sites at time 0 (pre-treatment) and time 1 (15 days weeks post-treatment). However, the difference between bleeding on probing as measured at time 0 and time 1 indicated an improvement on both sides, with a slightly greater improvement on the side treated with HA. SN - 0393-974X UR - https://www.unboundmedicine.com/medline/citation/29202570/Pyrrolopyrimidine_A_Multifaceted_Scaffold_in_Cancer_Targeted_Therapy_ DB - PRIME DP - Unbound Medicine ER -
Grapherence [↓2]

Related Citations

    More

    Others Viewed